SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?

被引：1
|
作者：
Theodorakopoulou, Marieta P. [1 ]
Sarafidis, Pantelis [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol 1, Thessaloniki, Greece
来源：
CLINICAL KIDNEY JOURNAL | 2024年 / 17卷 / 01期
关键词：
CHRONIC KIDNEY-DISEASE;
D O I：
10.1093/ckj/sfad272
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Oral SGLT2 inhibitors to treat diabetic cats
    Stockford, Sian
    VETERINARY RECORD, 2025, 196 (05) : 196 - 196
  • [42] FAERS reports of diabetic ketoacidosis with SGLT2 inhibitors
    Reactions Weekly, 2017, 1653 (1) : 7 - 7
  • [43] SGLT2 inhibitors increase the risk of diabetic ketoacidosis
    Reactions Weekly, 2016, 1603 (1) : 9 - 9
  • [44] SGLT2 inhibitors may cause diabetic ketoacidosis
    Reactions Weekly, 2015, 1553 (1) : 4 - 4
  • [45] SGLT2 inhibitors to prevent diabetic kidney disease
    Fioretto, Paola
    Vettor, Roberto
    Pontremoli, Roberto
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01): : 4 - 5
  • [46] Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Abrahami, Devin
    D'Andrea, Elvira
    Kim, Seoyoung C.
    Wexler, Deborah J.
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [47] SGLT2 inhibitors increase risk of diabetic ketoacidosis
    Reactions Weekly, 2017, 1656 (1) : 12 - 12
  • [48] SGLT2 inhibitors and diabetic ketoacidosis — a growing concern
    Guillermo E. Umpierrez
    Nature Reviews Endocrinology, 2017, 13 : 441 - 442
  • [49] SGLT2 inhibitors: diabetic ketoacidosis in the surgical setting
    Reactions Weekly, 2020, 1789 (1) : 10 - 10
  • [50] SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
    Kawanami, Daiji
    Matoba, Keiichiro
    Takeda, Yusuke
    Nagai, Yosuke
    Akamine, Tomoyo
    Yokota, Tamotsu
    Sango, Kazunori
    Utsunomiya, Kazunori
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
12345